Previous Article | Next Article ![]()
Journal of Bacteriology, March 2006, p. 1866-1874, Vol. 188, No. 5
0021-9193/06/$08.00+0 doi:10.1128/JB.188.5.1866-1874.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Bacteriology and the Center for the Study of Nitrogen Fixation, University of WisconsinMadison, Madison, Wisconsin 53706
Received 27 October 2005/ Accepted 19 December 2005
|
|
|---|
|
|
|---|
In enteric bacteria, the primary nitrogen signal molecule affecting PII function is glutamine, which is sensed by GlnD. Under nitrogen deficiency, glutamine levels are relatively low and the bifunctional GlnD serves as a uridylytransferase, modifying each subunit of the PII trimer (23). Under nitrogen-excess conditions, glutamine levels are high and glutamine-bound GlnD has the opposite activity, that of a uridylyl-removing enzyme (UR) to remove the UMP group from the modified PII. In the cyanobacteria, PII is phosphorylated (or not) in response to
-ketoglutarate (
KG) levels, an indicator of nitrogen status (14, 40, 57). Though the kinase remains unknown in these organisms, the phosphatase, PphA, senses and responds to
KG and is unrelated to GlnD (17, 47). In higher organisms, there is no apparent posttranslational modification of the PII homologs (53).
In all cases, however, PII is thought to act as a sensor as well, by directly binding
KG (8, 12, 29, 43). PII can also bind ATP (29), but its physiological role is unknown. In vitro analysis of the well-studied prokaryotic systems has shown that the presence or absence of these small molecules affects the modification of PII noted above (23, 29).
KG also affects the interactions of PII proteins with receptor proteins, at least in vitro (12, 23-25, 29, 33). Finally,
KG can also affect other regulatory proteins such NtcA, a transcriptional regulator in cyanobacteria (56, 58), and NrpR, a repressor for nif expression in Methanococcus maripaludis (31).
PII proteins act as trimers, and several structures have been solved, either with or without ATP, but all have been in the UMP-free form (4, 6, 48, 51, 54, 59-61) (see Fig. 1A, for the E. coli GlnB structure). In some structures, a region termed the T loop extends away from the bulk of the trimer, and it is at the tip of this loop that UMP (or PO42 in the case of the cyanobacteria) is attached. ATP binds near the lower portion of the T loop, and indirect evidence in both Escherichia coli and other organisms suggests that
KG binds adjacent to ATP (4, 26, 41). Each PII trimer is capable of binding three molecules each of
KG and ATP (23, 29).
![]() View larger version (33K): [in a new window] |
FIG. 1. Model of the structure of R. rubrum GlnB. (A) Ribbon model of the E. coli GlnB trimer (6). The B monomer is shown with a dark backbone. A single ATP molecule, whose position is based on the structure of ATP-bound GlnK of E. coli (60, 61), is shown at the interface of monomers A and B. The T loops are indicated, and at the tip of each is Tyr51, the site of uridylylation. (B) The same view, but with the R. rubrum wild-type residues altered in the GlnB* variants shown as space filled. Only residues on one face of the trimer are shown, and their respective monomer is indicated by the "A" or "B" preceding the residue name.
|
What then is the molecular role of UMP in affecting the interaction of PII and its receptor proteins? It is broadly believed that the T loop makes direct contact with appropriate regions of at least some receptor proteins (19, 26, 27, 36). We assumed this to be true and supposed that the uridylylated Tyr51 at the tip of the T loop might well also interact with the receptors. In this case, appropriate receptor proteins would or would not have surfaces that directly contact the uridylylated or the unmodified residue. We became somewhat skeptical of this simple model when we converted GlnJ of R. rubrum to perform a GlnB-specific function. The activity of NifA is posttranslationally activated by GlnB-UMP in R. rubrum (65, 68). GlnJ-UMP is unable to activate NifA, and we therefore systematically changed GlnJ residues to those of GlnB to determine the minimal set of residues that defined NifA's specificity for GlnB (68). The critical residues for interaction with NifA mapped to a large part of the GlnB surface, including positions far from the site of uridylylation (68). This seemed to imply that NifA would have to contact a very large GlnB surface, at least if the T loop was extended. Instead we proposed that, at least for this interaction, the UMP-T loop might move closer to the body of GlnB than has been found for the T loop in the solved UMP-free GlnB structures. Consistent with the notion of T-loop flexibility, some structures have failed to resolve this region of PII (4, 48, 59-61).
In the present work, we tried to expand our understanding of the NifA-contacting residues of GlnB by selecting for GlnB variants, termed GlnB*, that interacted better with NifA than did wild-type GlnB in the yeast two-hybrid system. In fact we found these GlnB* variants to be profoundly altered in both nitrogen sensing and interaction with receptor proteins. Based on these results, we propose a model in which the role of uridylylation is to cause a conformational change in GlnB to a form that signals nitrogen deficiency.
|
|
|---|
Construction of plasmids for two-hybrid analysis. About 350 bp of R. rubrum wild-type glnB was PCR amplified with two oligonucleotides with EcoRI and SalI sites at both ends, and cloned into pGBDU-C1 (20) to generate an in-frame fusion with the GAL4 DNA-binding domain, yielding pUX679. Similarly, R. rubrum wild-type draT, nifA, ntrB, and glnE were PCR amplified with two oligonucleotides with BamHI and PstI sites at both ends and cloned into pGAD-C1 (20) to generate an in-frame fusion with the GAL4 activation domain, yielding pUX682, pUX686, pUX688 and pUX1959, respectively.
Random PCR mutagenesis and yeast two-hybrid selection of mutants.
Mutations in glnB were generated with pUX679 (GAL4 DNA-binding domain-GlnB fusion) as a template and two oligonucleotides with EcoRI and SalI sites at both ends as primers using the GeneMorph II random mutagenesis kit (Stratagene, La Jolla, California). The mutagenized DNA was digested with EcoRI and SalI, and ligated with pGBUD-C1 (20). After transformation with E. coli DH5
, 5 x 104 independent colonies were pooled and the plasmids were isolated and used to transform Saccharomyces cerevisiae strain pAJ69 harboring pUX686 (GAL4 activation domain-NifA fusion) (UY19) by the lithium acetate method (15, 50). The transformants were selected on SD (a yeast minimal medium) plates lacking leucine, uracil, and histidine and containing 1.5 mM 3-amino-1,2,4-triazol, a competitive inhibitor of His3 protein (9). Plasmids were recovered from fast-growing colonies and then reintroduced into UY19 to exclude false positives. The glnB was sequenced using Big Dye Terminator v.3.1 cycle sequencing kit (Applied Biosystems) to localize the mutation positions.
Construction of R. rubrum mutants.
To construct the glnB glnD mutant, two plasmids pUX1295 (
glnD3::accC1) and pUX1299 (
glnD4::accC1) (67) were separately conjugated into UR717 (
glnB3) (65). Smr Nxr Gmr colonies were selected and then screened for Cms clones resulting from double-crossover events, and the two glnB glnD mutants were designated UR1665 and UR1666. In UR1665, glnD and aacC1 are transcribed in the opposite direction, while in UR1666 they are transcribed in the same direction. An R. rubrum mutant, UR1760 (glnB glnD nifH::lacZ), was obtained by conjugating plasmid pUX1831 (nifH::lacZ) (R. Kerby et al., unpublished results) into R. rubrum UR1665. Smr Nxr Gmr Kmr colonies were selected and replica printed to screen for Cms (Cmr is encoded by the vector sequence) colonies. R. rubrum UR1789 (
glnB
glnK glnJ::lacZ) was obtained by conjugating pUX2040 (glnJ::lacZ) (D. Wolfe et al., unpublished results) into UR757 (
glnB
glnK) (65). Smr Nxr Gmr Kmr colonies were selected and then screened for Cms clones resulting from double-crossover recombination events.
Expression of GlnB* variants in R. rubrum.
For integration of glnB alleles in single copy into the chromosome, a 2.5-kb fragment of R. rubrum glnB was cloned into a suicide vector, pUX19 (32), which was designated pUX1906. Six plasmids (from pUX2010 to pUX2015) producing GlnB* variants E15A, K17T, H42Q, L45P, V52D, and F55L, respectively, were constructed with pUX1906 as the template by the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, Calif.). Together with pUX1906, these six plasmids were transformed into E. coli strain S17-7 (52), then conjugated into UR1665 and UR1666 (glnB glnD) separately, and Smr Nxr Gmr Kmr colonies were selected. In the resulting strains (from UR1683 to UR1696), glnB or glnB* is expressed at normal levels from its own promoter. Multicopy plasmids expressing the selected GlnB* variants (pUX1999-2004) were constructed by inserting about 1-kb fragments carrying the glnB promoter and the appropriate glnB allele into the broad-host-range plasmid pRK404 (7). Together with pUX1998 (wild-type glnB), these six plasmids were transferred from E. coli into R. rubrum UR1665/UR1666 (glnB glnD), UR1760 (glnB glnD nifH::lacZ), and UR1789 (
glnB
glnK glnJ::lacZ) separately by triparental mating, yielding UR1669-1682, UR1761-1767, and UR1834-1840, respectively (16).
For overexpression of R. rubrum wild-type GlnB and five GlnB* variants (except E15A) in E. coli, a 0.4-kb fragment of glnB or glnB* was PCR amplified and cloned into pND706 (34) at NdeI and EcoRI sites and transformed into strain BK (
glnB
mdl-glnK::kan) obtained from Alex Ninfa (3). For each strain (UQ2549, and UQ4308-4312), a 10-ml overnight culture was inoculated into 500 ml of 2x LB medium supplemented with 100 µg/ml ampicillin and 25 µg/ml kanamycin. Cultures were incubated at 30°C until the optical density at 600 nm reached 1.2 to 1.7; the temperature was then shifted to 44°C, and growth continued for 4 h. Cells were harvested by centrifugation, resuspended in 50 mM Tris-HCl, pH 7.5, with 1 µg/ml leupeptin, frozen at 20°C overnight, and then lysed by sonication. Following precipitation with 45% (final) ammonium sulfate, the precipitant was resuspended in 50 mM Tris-HCl, pH 7.5, and the GlnB was purified to greater than 90% purity on a Q-Sepharose column. E. coli GlnD was purified from a strain with pDOP1 (28) by a protocol similar to that described for GlnB above, and purification to approximately 50% purity was achieved.
Uridylyltransferase assay.
The uridylyltransferase assay was performed as described previously. Reaction mixtures included 100 mM Tris-HCl, pH 7.5, 100 mM KCl, 25 mM MgCl2, ATP, and
KG as indicated, 1 mM dithiothreitol, 0.3 mg/ml bovine serum albumin, 0.8 µM GlnD, and 8 to 12 µM GlnB (23). Reaction mixtures were preincubated at 30°C for 2 min, started with the addition of 1 mM UTP, and incubated for 1 h at 30°C, before being stopped by the addition of 25 mM EDTA. Uridylylation was detected qualitatively using nondenaturing 12.5% polyacrylamide gel electrophoresis (PAGE) analysis, as described previously (2).
Protein immunoblotting. A trichloroacetic acid precipitation method was used for rapid protein extraction (63). GlnJ and GS Western blotting was performed as described previously (64, 67).
Assay for ß-galactosidase in liquid culture. R. rubrum cultures were first grown in SMN medium aerobically in the dark for 2 days and then inoculated into MG media at a 65-fold dilution. MG-grown cultures were anaerobically grown under light for 2 days, and NH4+ was added as described. ß-Galactosidase activity was measured by the standard protocol (38).
|
|
|---|
We assumed that GlnB would not be uridylylated in yeast, that improved interactions would result from changes in specific contact residues, and that such changes would energetically compensate for the absence of UMP. We expected that these changes would affect PII interaction with receptor proteins other than NifA in a varied fashion, depending on whether or not the changes happened to affect important contacts for those different receptors. In fact, the GlnB variants chosen for improved interaction with NifA were typically reduced in their ability to interact with two other receptors, NtrB and DRAT, in the two-hybrid assay. NtrB is known to interact with the nonuridylylated form of PII in E. coli (22). Although the situation with DRAT remains unknown, it is likely that it too interacts with nonuridylylated form of PII. In contrast to the initial hypothesis, the results described below suggest an admittedly simplistic model for the role of UMP: GlnB exists in two different functional forms, one signaling N sufficiency and the other N deficiency, and each of these forms interacts with one of two different sets of receptor proteins. In this model, uridylylation has the primary effect of shifting the equilibrium toward the N-deficiency form. The substitutions in the GlnB variants are then explained as those changes that shift that equilibrium toward the N-deficiency form, but in the absence of UMP. This in turn explains the uniform reduction in their interaction with NtrB, a receptor that favors the N-sufficiency form. We recognize that
KG and ATP also affect PII interaction with receptors and certainly also affect PII conformation (25, 29, 33); it is likely that multiple structural forms of PII exist, reflecting the nitrogen, carbon, and probably energy status in the cell. However, we only focus on the functional change by UMP here.
The two-hybrid screen with NifA yields variants that no longer require UMP for significant interaction with NifA in R. rubrum. To screen for GlnB variants that are improved for interaction with NifA, we mutagenized the glnB region in the yeast expression vector by error-prone PCR, producing approximately 1.5 mutations per clone, as determined by direct sequencing. These were then used as bait with an appropriate yeast clone carrying NifA. The wild-type controls showed a low but detectable level of interaction (Table 1 and Fig. 2), and the frequency of mutants with improved growth (and therefore improved interaction) was approximately 0.1%. The plasmids containing the glnB alleles were isolated and returned to an identical yeast strain to verify that they were causal to the improved growth. They were then sequenced, and 15 different variants were detected in a total of 36 mutants (Table 1). These GlnB* variants differed in their specific degrees of interaction in this assay, and most were significantly better than wild-type GlnB, although some, such as E15A and L45M GlnB, were only marginally improved (Table 1 and Fig. 2).
|
View this table: [in a new window] |
TABLE 1. GlnB* variants identified for their improved interaction with NifA in the yeast two-hybrid systema
|
![]() View larger version (47K): [in a new window] |
FIG. 2. Yeast two-hybrid results demonstrate relative interaction between selected GlnB* variants and NifA, DRAT, and NtrB. Strains expressing the proteins indicated were patched onto different plates that are increasingly restrictive for growth and therefore increasingly demanding of GlnB interaction with its receptors, from left to right. In the first four columns, the demand is for growth in SD medium without histidine and in the presence of increasing amounts of 3-amino-1,2,4-triazol (3-AT), a competitive inhibitor of His3 protein (9). The right column demands growth in the absence of adenine (Ade). WT, wild type. The experiment was performed in quintuplicate, but only a single set of responses is shown.
|
KG binding. We suppose that this GlnD-independent nitrogen regulation of GlnB can occur in a wild-type background as well, but it is less striking because the regulation is overshadowed by the uridylylation event. The relatively high level of nifH::lacZ expression remaining in these GlnB* mutants indicates that they still partially mimic the uridylylated form even under NH4+-excess conditions. H42Q GlnB seems to be particularly resistant to this NH4+ addition, so perhaps its interaction with NifA happens not to be perturbed by
KG binding because of the H42Q substitution. We do not know the reason for the increase in activity in the presence of NH4+ in the strain with E15A GlnB. |
View this table: [in a new window] |
TABLE 2. NifA activation by GlnB* variants under several conditionsa
|
Two-hybrid analyses of the GlnB* variants show that interactions with other PII targets are also altered, and in a pattern consistent with the GlnB* variants mimicking GlnB-UMP. The original hypothesis was that the GlnB* variants would be specifically improved for NifA interaction, but we could not predict the effect of the substitutions on interactions with other receptor proteins. We had already identified two other R. rubrum receptor proteins that interacted well with wild-type GlnB in the yeast system, NtrB and DRAT (Fig. 2), and these receptors had also been detected in the yeast system by others with homologous proteins from other organisms (36, 44, 49). NtrB is thought to interact exclusively with the nonuridylylated form of GlnB (21, 23). Based on the present data, we assume that the nonuridylylated form of GlnB is also critical for interaction with DRAT. We then tested the ability of the selected set of GlnB* variants to interact with these receptors in the yeast system. Each of these GlnB* variants interacted differently with NtrB and DRAT, but the striking result was that all but E15A interacted less well with each of these two receptors than did wild-type GlnB (Fig. 2). The exception, E15A, remained similar to the wild type for NtrB interaction, but it was also the variant with the least improvement in NifA interaction, so this correlation is not surprising. We note that the specific interactions of each GlnB* variant with DRAT and NtrB are not identical, but they are uniformly weaker than those of the wild type. We interpret the different patterns of interaction for each GlnB* to mean that the substitution in each GlnB* variant does cause some receptor-specific perturbations, presumably by either direct or indirect effects on GlnB structure. However, the pattern of uniformly decreased interactions (compared to those of the wild type) with both receptors that typically bind the non-UMP form requires a rather different explanation, such as the equilibrium shift model described above.
The GlnB* variants continued to interact with GlnE (data not shown), but this result is complicated by the apparent fact that both GlnB and GlnB-UMP are thought to interact with GlnE, albeit at different sites (18). As a consequence, an equilibrium shift in GlnB might change the site of GlnE interaction, but not necessarily its magnitude. Further analysis using fragments of GlnE should prove informative. No interaction of wild-type GlnB or the GlnB* variants was detected with DRAG or AmtB1, but such negative results are not interpretable and might be due to a disoriented fusion protein (data not shown).
The important substitutions in the GlnB* variants are found predominantly, but not exclusively, near the T loop. Figure 1A shows a model of R. rubrum GlnB based on the known structure of E. coli GlnB (6, 60), and the three T loops and an ATP-binding site are indicated. The wild-type residues altered in the GlnB* variants are shown as space filled in same structure in Fig. 1B. For clarity, only GlnB* residues on one face of the trimer are shown, although residues Lys12, Glu15, and Arg72 from two monomers are repeated on both the left and right sides. Several points are evident. (i) While a number of changes are found in and near the T loop, many GlnB* residues identified in the two-hybrid analysis lie elsewhere. (ii) There is not an obvious clustering of substitutions near the known ATP-binding site, although indirect effects on this region cannot be ruled out. Though we propose that these substitutions might each have the effect of shifting the GlnB equilibrium to a new structure, it is premature to speculate on that structure. We recognize that several substitutions, such as T29M, A49P, and T83N, have been found in E. coli GlnB that altered its interaction with other receptors (26). All of these wild-type residues are conserved in all three R. rubrum PII homologs, but substitutions at these positions were not detected in our selection. It is possible that the phenotypes of these variants simply do not satisfy the initial selection that we imposed.
When expressed at normal levels, the GlnB* variants are altered in their regulation of NtrB and GlnE.
We examined the ability of these GlnB* variants to regulate the two receptors that are most critical for cell growth, NtrB and GlnE. First, we examined the effects of GlnB* variants on GlnE activity by Western analysis of GS from cells grown under nitrogen-limiting conditions and then after NH4+ addition. As shown in Fig. 3, GS in the UR2 (wild-type and glnD+) strain (lanes 15 and 16) was substantially nonadenylylated before NH4+ addition and adenylylated afterwards. In the glnD mutant background, the wild-type GlnB (UR1683) lacks uridylylation and therefore signals nitrogen sufficiency, so that GS is adenylylated under both conditions (lanes 1 and 2), similar to previous results (67). In a number of the GlnB* variants, except for E15A, whose relatively weak phenotype was noted above, a distinct nonadenylylated band is detectable before NH4+ addition, consistent with these variants mimicking the uridylylated form even in the absence of GlnD. In some GlnB* variants, especially in H42Q (UR1689), L45P (UQ1691), and F55L (UQ1695), the deadenylylated band predominates, indicating that the regulation of GlnE activity by these GlnB* variants is poised toward demodification of GS even in this GlnD background. More interestingly, all GS became adenylylated after NH4+ addition, again indicating that these GlnB* variants are still able to respond to a nitrogen signal in the absence of GlnD. It is important to note that the pattern of effectiveness of GlnB* variants for regulating GlnE does not completely match the pattern for NifA described above, nor does it match that for NtrB to be described below. This might either mean that the specific substitutions in the GlnB* variants have also altered contact surfaces for different receptor proteins or that these substitutions alter either
KG or ATP binding or their effect on receptor interaction.
![]() View larger version (45K): [in a new window] |
FIG. 3. Perturbed modification of GS in strains expressing GlnB* variants demonstrates altered regulation of GlnE activity. The figure shows a Western blot of a sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel developed with antibody to GS, where adenylylated GS appears as the upper of the two bands. All strains are glnB glnD but express wild-type (WT) GlnB (UR1683) or GlnB* variants (UR1685, -1687, -1689, -1691, -1693, and -1695) in single copy from an integrated plasmid. For each pair of lanes, the first shows GS from the cells grown in MG medium (nitrogen deficient, since glutamate serves as sole nitrogen source), and the second shows the GS 60 min after the addition of 10 mM NH4Cl. Lanes 15 and 16 contain similar preparations from UR2 (wild-type R. rubrum).
|
|
View this table: [in a new window] |
TABLE 3. NtrC activation by GlnB* variants
|
![]() View larger version (31K): [in a new window] |
FIG. 4. GlnJ accumulates in a glnB glnD background when GlnB* variants are expressed in single copy from an integrated plasmid. Cells were grown in MG medium, and proteins from crude extracts were separated by SDS-PAGE and immunoblotted with antibody against R. rubrum GlnJ. UR2 is the R. rubrum wild type (WT). UR1683 contains wild-type GlnB, while UR1685, -1687, -1689, -1691, -1693, and -1695 contain the GlnB* variants.
|
The GlnB* variants are perturbed in their requirements for uridylylation in vitro. Because of the substantially altered behavior of the GlnB* variants in vivo, we presumed that their in vitro behavior would also be different and informative. We therefore purified and analyzed the modification requirements of a subset of GlnB* variants, using GlnD purified from E. coli.
Under our assay conditions, wild-type GlnB is substantially uridylylated only in the presence of high levels of
KG and ATP (Fig. 5). This is somewhat in contrast to the case of E. coli GlnB, using the same GlnD, where rather lower levels (33 µM) of
KG are sufficient for full modification (23).
![]() View larger version (72K): [in a new window] |
FIG. 5. In vitro uridylyltransferase activity assays on wild-type (WT) GlnB and GlnB* variants show that many of these variants are dramatically altered in their properties as GlnD substrates. Wild-type GlnB and four GlnB* proteins were overexpressed and purified from E. coli (UQ2549, UQ4308, UQ4310, UQ4311, and UQ4312) and then used as substrates of E. coli GlnD as described in Materials and Methods. The specific GlnB protein used in each portion of the gel is shown at the top, and below that are the specific conditions for the samples in each lane. These are native gels, so that the protein trimer runs at as many as four positions, depending on the number of UMP groups per trimer, with the fully uridylylated form moving the fastest.
|
KG and ATP levels, demonstrating a higher propensity for uridylylation than wild-type GlnB. (The slight modification of K17T GlnB before treatment apparently reflects a slight difference in culture conditions from which this variant was harvested.) V52D GlnB is almost completely modified at high
KG with either low or high ATP levels, while F55L GlnB is almost completely modified at both low
KG and low ATP levels. L45P and H42Q GlnB were both rather similar to wild-type GlnB in their uridylylation properties under these conditions (data not shown), and E15A GlnB was not analyzed.
We cannot directly interpret these differences in terms of biological function. Nevertheless, the results do show that many of these variants are more readily uridylylated under ATP- and
KG-limiting conditions than is wild-type GlnB. The simplest explanation might be that these variants mimic the form of the protein that is stabilized by that modification and are therefore better substrates for uridylylation. While we do not know why all tested variants do not behave more similarly, it is possible that these substitutions happen to have a secondary effect on GlnB binding by GlnD. The different uridylylation requirements of these GlnB* variants need to be further investigated.
Working hypothesis. The notion that uridylylation has a profound effect on PII function and that it shifts PII from the N-sufficiency form to the N-deficiency form is well known. Our results suggest a model in which a primary role of uridylylation is to stimulate a global conformational change, which is substantially mimicked by these GlnB* variants. We will discuss the current paradigms of PII regulation by covalent modification and then put our results in a larger context.
Work from Ninfa's laboratory has elegantly shown that
KG and ATP bind to PII synergistically and that they have the potential to affect uridylylation and deuridylylation (23). Similar results have been seen in cyanobacteria, although PII is regulated by phosphorylation (13). These analyses have led to a multistate model of PII, where the major effect is the result of uridylylation, but where
KG has additional conformational effects that affect certain PII-receptor interactions. The situation in the cyanobacteria has differences noted in the introduction, but similarities as well. Here again PII binds
KG and ATP, and the presence of these is thought to be necessary for phosphorylation in vivo (12).
We recognize the complications inherent in the synergistic binding of ATP and
KG and the anti-cooperative binding of
KG (23, 29), but suggest that the UMP effect might be viewed more simply. That is, because GlnB* variants chosen for improved interaction with NifA in yeast are also uniformly poorer than wild-type GlnB for interaction with NtrB and DRAT, a two-state model for these differences is the simplest hypothesis. Moreover, because these GlnB* variants mimic the uridylylated form of GlnB by several analyses, it is our hypothesis that such a two-state model can account for uridylylation effects as well. We assume these two states represent a global conformational change, perhaps involving in the T loop, but the nature of that change is completely unclear at present.
The fact that the GlnB* variants are altered in their interaction with so many receptor proteins is most easily explained by such a global conformational change. However, the fact that different GlnB* variants show somewhat different responses to specific receptors is consistent with the idea that some of these substitutions also directly or indirectly alter residues that are more or less critical for interaction with specific receptors.
The results presented here have revealed a phenotypically striking class of GlnB variants in which single substitutions profoundly alter central nitrogen regulation. The results imply a model in which the role of uridylylation is to promote a conformational change in the protein.
We thank Alex Ninfa for generously providing a number of strains critical for GlnB and GlnD overexpression, Betty Craig and Philip James for the yeast strains and plasmids for the yeast two-hybrid system, and David Ollis for expression vectors. We thank Jose Serate for purifying GlnD and GlnB proteins, Edward Pohlmann and Jonathan Jacobs for their help with some experiments, Robert Kerby and David Wolfe for providing unpublished plasmids, and Hwan Youn for generating structure pictures. We also thank David Wolfe and Hwan Youn for helpful criticisms of the work and the manuscript.
|
|
|---|
-ketoglutarate that regulate nitrogen metabolism. Curr. Opin. Microbiol. 8:168-173.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»